Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Alopecia Market?

The market size of alopecia has seen a consistent growth over the past few years. It is projected to increase from $11.05 billion in 2024 to $11.6 billion in 2025, showing a compound annual growth rate (CAGR) of 4.9%. The expansion in the previous years can be attributed to increased diagnosis awareness, amplified consumer demand, a rising number of international medical tourism centres, and improved reimbursement situations.

What Growth Rate Is Forecasted for the Alopecia Market by 2029?

In the coming years, the alopecia market is projected to experience consistent expansion. It is set to reach a worth of $13.88 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 4.6%. Such growth during the forecast period is primarily due to an aging population, heightened awareness of cosmetic issues, increasing lifestyle factors, and a rise in healthcare spending. Future trends to watch for during this period incorporate progress in therapeutic strategies, biotechnological advancements, and the escalating use of artificial intelligence (AI) and machine learning (ML) in alopecia studies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12862&type=smp

Which Key Companies Are Shaping the Future of the Alopecia Market?

Major companies operating in the alopecia market are Pfizer Inc., Johnson and Johnson Ltd., Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi SA, GlaxoSmithKline PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Allergan PLC, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Intertek Group PLC, Dr. Reddy’s Laboratories Ltd., Cipla Limited, Almirall S.A., Aclaris Therapeutics Inc., Curallux LLC, Theradome Inc., Lexington International LLC, Histogen Inc., Apira Science Inc.

Which Factors Are Driving Demand in the Alopecia Industry?

Expectations for the alopecia market are buoyed up by the rising occurrence of hair loss. Hair loss, whether partial or complete from typically hairy parts of the body, heightens the need for alopecia treatment as this therapy solves several hair loss-related problems by promoting hair regrowth, formulating customised treatment strategies, integrating different therapies, and dealing with the physical aspect of hair loss. All these contribute significantly to improved emotional health and quality of life for the patient. For example, in April 2023, the National Health Commission in China reported that over 250 million Chinese exhibited symptoms of hair loss, with 42% of this population aged between 26 and 30. Similarly, the Statistic Brain Research Institute in the US, reported that around 40% of men are likely to have visible hair loss by the time they reach 35, as of February 2023. Therefore, mounting cases of hair loss continue to bolster the alopecia market. The alopecia market is also likely to benefit from increasing proactivity in government measures. This broad category covers any kind of specific actions, policies, schemes, or efforts initiated by governmental bodies at different levels, designed to tackle specific problems, reach particular objectives, or further societal welfare. These initiatives significantly contribute to progress in alopecia treatment by funding research, assisting and hastening the approval procedures for new drugs and therapies, and launching public awareness drives to enlighten public and medical personnel about alopecia. For instance, in June 2022, Heather Humphreys, an Ireland-based social protection minister introduced a new scheme under gov.ie (Government of Ireland) that would grant $525.36 (€500) to individuals suffering from illness-related hair loss to finance wigs, hairpieces, or alternative hair replacements. The lives of patients with alopecia and other hair loss conditions are significantly improved because of such initiatives. In conclusion, the intensification of governmental initiatives is a major driver propelling the growth of the alopecia market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12862&type=smp

How Is the Alopecia Market Segmented by Several Divisions?

The alopecia market covered in this report is segmented –

1) By Type: Alopecia Areata, Androgenetic Alopecia, Alopecia Totalis, Traction Alopecia, Cicatricial Alopecia, Other Types

2) By Treatment: Pharmaceutical, Low Level Laser Therapy (LLLT) Devices, Hair Transplant, Regenerative Medicine, Other Treatments

3) By Gender: Male, Female

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

5) By End-User: Dermatology Clinics, Homecare Settings, Other End-Users

Subsegments:

1) By Alopecia Areata: Patchy Alopecia Areata, Persistent Patchy Alopecia Areata, Alopecia Universalis, Diffuse Alopecia Areata, Ophiasis

2) By Androgenetic Alopecia: Male Pattern Baldness, Female Pattern Hair Loss

3) By Alopecia Totalis: Complete Scalp Hair Loss

4) By Traction Alopecia: Frontal Traction Alopecia, Occipital Traction Alopecia

5) By Cicatricial Alopecia: Lichen Planopilaris, Discoid Lupus Erythematosus, Central Centrifugal Cicatricial Alopecia, Frontal Fibrosing Alopecia, Folliculitis Decalvans

6) By Other Types: Telogen Effluvium, Anagen Effluvium, Trichotillomania

What are the Emerging Market Trends Driving the Growth of the Alopecia Industry?

Leading enterprises in the alopecia market are directing their efforts towards creating groundbreaking therapies to establish a competitive edge. For instance, in June 2022, Eli Lilly and Company and Incyte, both pharmaceutical companies based in the US, announced their approval for luminant oral tablets from the United States Food and Drug Administration (FDA), a federal agency in the US. This approval makes it the first systemic therapy endorsed by the FDA for severe alopecia areata in adults. In addition, Olumiant has also been identified as a treatment for adult patients suffering from moderately to severely active rheumatoid arthritis who haven’t had an adequate response to one or more tumor necrosis factor (TNF) blockers.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/alopecia-global-market-report

Which Regions Are Driving Growth in the Alopecia Market?

North America was the largest region in the alopecia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the alopecia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12862

This Report Delivers Insight On:

1. How big is the alopecia market, and how is it changing globally?

2. Who are the major companies in the alopecia market, and how are they performing?

3. What are the key opportunities and risks in the alopecia market right now?

4. Which products or customer segments are growing the most in the alopecia market?

5. What factors are helping or slowing down the growth of the alopecia market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model